Digital Coaches at Dario (DRIO) Significantly Reduce Depression.

63% of Users Show Significant Improvement After Impact of Digital Coaching and Breathing Exercises as Part of the Dario Health Platform.

Mass General Brigham to Invest $100 Million in Telehealth and Digital Tools.

The five-year project aims to support consumer-centered care and patient engagement technology use. PatientEngagementHIT.com "Project...
biotech stock review

7 Million Telehealth Users This Year, Expected to Drive Revenues to $36 Billion in...

As boomers age, experts predict the telehealth market will grow from a $14.3 billion industry in 2013 to a $36.2 billion...
Biotech Stock Review,

Premier Health (PHGRF) Announces Definitive Agreement to Acquire Livecare.

Livecare is an established leader in the Canadian digital health spaceHave provided over 27,000 telemedicine visitsService over 500 independent active health practitioner...

True Nature|Mitesco (TNTY). Coverage Report Issued.

Record Volume and Gradually Rising Price Portends to Higher Prices in 2020 as True Nature Executes on Recently Announced Incubator Strategy.
Julie R Smith, True Nature, Mitesco

True Nature|Mitesco President & COO, Julie Smith Interview.

Julie R. Smith is a seasoned senior executive...
Mitesco, Biotech Stock Review

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter to Board.

True Nature Holding, Inc. DBA Mitesco, Inc. Adds Distinguished Healthcare Executive to Board of Directors.

Hapbee Closes $6.5 Million Private Placement and Provides Corporate Update.

VANCOUVER, BC, July 17, 2020 /PRNewswire/ - Hapbee Technologies, Inc. ("Hapbee" or the "Company"), a wellness technology company developing the revolutionary Hapbee wearable, is pleased to announce...
Roland Rick Perry, Biotech Stock Review

CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.

“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.”

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...